GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Enterprise Value

Roche Holding AG (Roche Holding AG) Enterprise Value

: $218,342 Mil (As of Today)
View and export this data going back to 2002. Start your Free Trial

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Roche Holding AG's Enterprise Value is $218,342 Mil. Roche Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $16,991 Mil. Therefore, Roche Holding AG's EV-to-EBIT ratio for today is 12.85.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Roche Holding AG's Enterprise Value is $218,342 Mil. Roche Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $20,917 Mil. Therefore, Roche Holding AG's EV-to-EBITDA ratio for today is 10.44.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Roche Holding AG's Enterprise Value is $218,342 Mil. Roche Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $68,490 Mil. Therefore, Roche Holding AG's EV-to-Revenue ratio for today is 3.19.


Roche Holding AG Enterprise Value Historical Data

The historical data trend for Roche Holding AG's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 285,325.59 306,535.09 356,365.15 272,630.75 259,079.24

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 356,365.15 292,594.75 272,630.75 268,174.89 259,079.24

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG Enterprise Value Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Enterprise Value falls into.



Roche Holding AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Roche Holding AG's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Roche Holding AG's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG  (OTCPK:RHHBY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Roche Holding AG's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=218342.005/16991.148
=12.85

Roche Holding AG's current Enterprise Value is $218,342 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Roche Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $16,991 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Roche Holding AG's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=218342.005/20916.69
=10.44

Roche Holding AG's current Enterprise Value is $218,342 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Roche Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $20,917 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Roche Holding AG's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=218342.005/68490.408
=3.19

Roche Holding AG's current Enterprise Value is $218,342 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Roche Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $68,490 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG Enterprise Value Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (Roche Holding AG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG (Roche Holding AG) Headlines

From GuruFocus

Analysts Tab Veeva Systems as a Top Value Pick

By Barry Cohen 05-25-2022